Navigation Links
LCA Hails International Investigators Studying Lung Cancer
Date:9/4/2007

Recommendations to Help Doctors and Patients More Precisely Stage, Diagnose

and Treat Lung Cancer

SEOUL, South Korea, Sept. 4 /PRNewswire-USNewswire/ -- Lung Cancer Alliance (LCA), the only US-based organization devoted exclusively to patient support and advocacy for those living with or at risk for lung cancer, hailed today's presentation by lead investigators of the International Association for the Study of Lung Cancer (IASLC) at the 12th World Conference on Lung Cancer (WCLC), as a significant development in how doctors and patients will more precisely stage, diagnose and treat lung cancer.

Every seven years international staging guidelines undergo a reevaluation to determine whether changes need to be made to the staging classification system. This is important because precise staging will provide clinicians with a common basis for the selection of the clinical management to minimize possible side effects while optimizing the chance of a favorable outcome for patients.

The IASLC study, which collected data on more than 100,000 patients worldwide, confirmed that in the last decade improvements in understanding tumor characteristics, emergence of new anti-cancer therapy and advancements in technology, particularly CT and PET scans, have allowed for a more precise analysis of tumor (T), lymph node (N) and metastasis (M) descriptors that make up the lung cancer staging system.

"Patients diagnosed with lung cancer will now benefit from a more accurate assessment of their disease, its staging and treatment protocols", said Laurie Fenton Ambrose, President of Lung Cancer Alliance. "By continuing to refine our knowledge -- we will more positively impact patient outcomes. I applaud IASLC for significant contribution in this area."

The IASLC study recommendations are due to be implemented in 2009 upon publication by the International Union Against Cancer and the American Joint Committee on Cancer.

Patients will not be negatively impacted by this reclassification.

Lung Cancer Alliance (http://www.LungCancerAlliance.org) is the only national non-profit organization solely dedicated to patient support and advocacy for people living with, or at risk for, lung cancer. As the number one cancer killer, lung cancer will kill more than 160,000 Americans and 1 million people worldwide this year alone.


'/>"/>
SOURCE Lung Cancer Alliance
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. LCA Hails Congressional Front Against Pink Camel Cigarette Campaign
2. PETA Hails McCartney for Boycotting Animal-testing Charities
3. International community warns India on HIV situation
4. Key step forward on International Health Rules
5. ICMR along with other International Research organisation with drug development for Neglected Diseases
6. International Osteoporosis Research Centre To Be Started In India.
7. Indian hospitals require International Accreditation
8. International Conference On Malaria - Laveran To Genomics
9. Delhi To Host International Women’s Congress From Nov 2
10. International conference on Ayurveda to be held on Kerala
11. International Teleradiology: The Future Of Radiologic Diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ... , "Film editors can give their videos a whole new perspective by using the ... CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
Breaking Medicine Technology: